M3 EU launches M3 Production, a complete solution to transform pharmaceutical marketing
April 15, 2024 – Pharmaceutical – M3 EU, M3 Production, pharmaceutical marketing
15 April 2024 — Oxford, UK — M3 EU is delighted to launch M3 Production, a specialist pharmaceutical production service designed to streamline marketing efforts, optimise resources and enhance the overall impact of pharmaceutical marketing campaigns. M3 Production combines campaign strategy, bespoke content creation and evolution of content to guarantee campaign success to its partners.
The pharmaceutical sector is increasingly recognising the ineffectualness and limitations of juggling multiple vendors for marketing execution. This approach can lead to inconsistent messaging, increased campaign costs and operational inefficiencies. M3 Production addresses these challenges by providing a singular, integrated partner that understands the unique needs of pharmaceutical companies. In doing so, M3 EU delivers streamlined operations, cohesive strategies and a unified brand voice across all channels.
M3 Production encompasses a suite of services, including:
- Localising campaign assets: Tailoring marketing materials to meet the linguistic and regulatory demands of each market to ensure that global campaigns are both locally effective and compliant
- Maximising assets: Creatively repurposing existing marketing assets across various platforms to enhance reach and meet key performance indicators
- Dedicated campaign tracking and guaranteed engagement: Offering ongoing analysis and adjustment of marketing strategies to guarantee engagement and support objectives
- Content and design excellence: Dedicated content creation, design, medical and industry expertise with access to top-tier designers, medical writers, data researchers, analysts and project managers
- Unparalleled access and support: Leveraging M3 EU’s extensive network of 6 million doctors worldwide, coupled with comprehensive support from a dedicated production team.
M3 Production is able to offer unrivalled support to its clients. By consolidating services under the M3 EU umbrella, pharmaceutical companies can achieve significant economies of scale, simplifying the marketing process and reducing the costs associated with managing multiple vendors. Additionally, by centralising knowledge and expertise within M3 EU, pharmaceutical clients can be sure that all marketing materials reflect a consistent brand message, tone and aesthetic, reinforcing brand integrity. Finally, M3 EU’s deep understanding of the internal approval process within pharmaceutical companies means that it is able to deliver content with efficiency and orchestrate more timely campaign launches.
Tim Russell, executive vice president of M3 EU, “The launch of M3 Production represents a paradigm shift in pharmaceutical marketing, offering a path to more efficient, cohesive and impactful marketing efforts. The capabilities of the M3 EU team, coupled with widespread engagement and channel access, means that M3 EU is able to deliver tangible KPIs that support brand engagement strategies in order to ensure measurable success for every campaign.”
About M3 EU:
M3 EU is a leading global provider of digital solutions in the medical communications field. In the fast-changing world of healthcare, M3 EU is passionate about driving excellence to achieve outstanding patient outcomes, and it provides a range of market-leading services to reach and engage doctors with clinically relevant information. Over the last two decades, M3 EU has achieved growth worldwide through acquisition of best-in-market companies and expansion of its services. Visit: eu.m3.com.
